SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) |
3 Months Ended | |||
---|---|---|---|---|
Apr. 17, 2025 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
|
Subsequent Event [Line Items] | ||||
Impairments of goodwill | $ 0 | $ 0 | ||
Medicare cost report settlement reserves | 2,000,000.0 | $ 2,100,000 | ||
Contractual allowances | 17,500,000 | |||
Contractual and related allowance adjustments | $ 3,200,000 | |||
Subsequent Event [Member] | ||||
Subsequent Event [Line Items] | ||||
Reverse stock split | 1-for-10 reverse stock split, such that every 10 shares of Common Stock will be combined into one issued and outstanding share of Common Stock | |||
Share price | $ 0.0001 |
X | ||||||||||
- Definition Contractual allowance related adjustments. No definition available.
|
X | ||||||||||
- Definition Contractual allowances. No definition available.
|
X | ||||||||||
- Definition Medicare cost report settlement reserves current. No definition available.
|
X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|